|
A cohort study among workers exposed to benzene in China
|
Z01 CP010120-02060
|
$1,557,754
|
Hayes, Richard
|
DCEG (NCI)
|
|
A Follow-up Study for Causes of Illness in Black Women
|
5R01CA058420-15
|
$1,680,267
|
Rosenberg, Lynn
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Genetic Test for Lung Cancer Early Detection
|
1R03CA133956-01
|
$75,000
|
Jiang, Feng
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
A Hospital-based Case-Control Study of Non-smoking Women in Xuan Wei and Fu Yuan,
|
Z01 CP010121-10349
|
$492,237
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A Longitudinal Study of the Predictors of Smoking in Women in Late Midlife
|
1R01CA122128-01A2
|
$592,812
|
BROOK, JUDITH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A lung cancer symptom assessment and management intervention
|
1R01CA125256-01A2
|
$540,027
|
COOLEY, MARY
|
DANA-FARBER CANCER INSTITUTE
|
|
A Microfluidic Platform for Early Detection and Prognostication of Cancer
|
5R03CA132189-02
|
$54,000
|
Wheeler, Aaron
|
UNIVERSITY OF TORONTO
|
|
A Molecular Basis for Neuroendocrine Carcinogenesis
|
5R01CA112405-04
|
$233,253
|
GRIMES, H
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
A mouse model of stem cell deregulation and lung cancer
|
5R01CA076354-08
|
$264,921
|
LOCKER, JOSEPH
|
YESHIVA UNIVERSITY
|
|
A Multi-State Study of Cancer Treatment and Outcomes Among American Indians
|
5R01CA125231-02
|
$426,676
|
RAMSEY, SCOTT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
A Multilevel Analysis of Predictors of Successful Teen Smoking Cessation in the N
|
1R03CA136013-01
|
$73,250
|
Branstetter, Steven
|
WEST VIRGINIA UNIVERSITY
|
|
A Non-small Cell Lung Cancer Tissue Microarray to Analyze Protein Expression
|
Z01 CP 010164
|
$210,949
|
Jen, Jin
|
CCR (NCI)
|
|
A Phase 2 Trial of Dasatinib in Patients with NSCLC and Acquired Resistance to Er
|
5R21CA130343-02
|
$224,400
|
MILLER, VINCENT
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Phase I/II Clinical Trial of Intravenous (I.V.) Calcitriol with Fixed Doses of
|
1R21CA128193-01A1
|
$412,976
|
RAMNATH, NITHYA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
A Pilot Smoking Cessation Study for Newly Diagnosed Lung Cancer Patients
|
5R03CA130722-02
|
$87,500
|
PARK, ELYSE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
A pilot study of lung cancer and hematopoietic malignancy in the Guangzhou, China
|
Z01 CP010120-10365
|
$31,369
|
Hayes, Richard
|
DCEG (NCI)
|
|
A randomized phase II study of erlotinib with or without the anti-IGF-1R monoclon
|
1R21CA135595-01
|
$369,078
|
Camidge, Ross
|
UNIVERSITY OF COLORADO DENVER
|
|
A Sensitive and Automated Diagnostic Assay for Lung Cancer
|
1R21CA135382-01
|
$168,750
|
Jiang, Feng
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
A Simulation of Tobacco Policy, Smoking and Lung Cancer
|
5U01CA097450-07
|
$219,011
|
LEVY, DAVID
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
A Web-Based Smoking Intervention for Cancer Survivors
|
5R01CA106914-05
|
$547,992
|
EMMONS, KAREN
|
DANA-FARBER CANCER INSTITUTE
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
ABC Transporters in Human Disease and Multidrug Resistance
|
Z01 BC 005725
|
$579,181
|
Dean, Michael
|
CCR (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accurate Models for Predicting Radiation-Induced Injury
|
5R01CA115748-03
|
$226,927
|
DAS, SHIVA
|
DUKE UNIVERSITY
|
|
ACOSOG Central Specimen Bank
|
5U24CA114736-04
|
$340,041
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
2U10CA076001-12
|
$3,011,166
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
ACOSOG Competing Renewal
|
3U10CA076001-12S1
|
$342,900
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
Activation of checkpoint pathways in cancer
|
5R01CA118827-03
|
$186,141
|
Halazonetis, Thanos
|
UNIVERSITY OF GENEVA
|
|
Addressing Parental Smoking by Changing Pediatric Office Systems
|
5R01CA127127-02
|
$713,115
|
WINICKOFF, JONATHAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Adenocarcinoma of the Lung: role of NNK susceptibility
|
5R01CA055769-18
|
$582,839
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Advanced Anatomic and Functional Response Assessment in Lung Cancer
|
5R01CA125143-02
|
$355,300
|
Schwartz, Lawrence
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Advanced Therapeutic Platforms for Cancer Therapy
|
N43CO800067-000
|
$149,860
|
REDDY, RAM
|
NEXT GENERATION THERAPEUTICS, INC.:11507
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-23
|
$327,432
|
IGLEHART, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Airway gene expression in smokers: an early diagnostic biomarker for lung cancer
|
5R01CA124640-02
|
$308,750
|
SPIRA, Avrum
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Alpha-1 AD Carriers and Lung Cancer Risk
|
5R01CA080127-08
|
$524,374
|
YANG, PING
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
American/Australian Mesothelioma Consortium
|
3U01CA111295-03S1
|
$169,500
|
PASS, HARVEY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
An Econometric Analysis of Cigarette Price Search and Tax Incidence
|
1R21CA131600-01A1
|
$138,600
|
KENKEL, DONALD
|
CORNELL UNIVERSITY ITHACA
|
|
An exploratory study to integrate cell phones into RDD health surveys
|
5R21CA129474-02
|
$95,266
|
DELNEVO, CRISTINE
|
UNIV OF MED/DENT NJ-SCH OF PUBLIC HEALTH
|
|
An Innovative Telephone Intervention for HIV+ Smokers
|
5R01CA097893-03
|
$491,603
|
GRITZ, ELLEN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-02
|
$419,084
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
Analyses of human T regulatory cells
|
Z01 BC 010973
|
$393,596
|
Tsang, Kwong
|
CCR (NCI)
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
Z01 BC 010425
|
$487,860
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
Analysis of the p53 in vivo using a unique mouse model
|
2R01CA100193-06
|
$335,365
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Analysis of Tobacco Industry Documents
|
5R01CA087472-09
|
$633,869
|
GLANTZ, STANTON
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Angiogenesis imaging
|
Z01 BC 010714
|
$440,297
|
Choyke, Peter
|
CCR (NCI)
|
|
Angioprevention of Lung Tumorigenesis by Silibinin
|
5R01CA113876-04
|
$288,389
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Anti-Angiogenic and Tumorcidal Drugs Against Lung Carcinoma
|
1R43CA130506-01A1
|
$200,594
|
OEHLEN, BERT
|
ANGION BIOMEDICA CORPORATION
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|